FIBROBIOLOGICS, INC. (FBLG)
FibroBiologics Announces First Patients Dosed in Phase 1/2 Clinical Trial Evaluating CYWC628 for the Treatment of Diabetic Foot Ulcers
COCRYSTAL PHARMA, INC. (COCP)
Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer
AVALYN PHARMA INC. (AVLN)
Avalyn Reports First Quarter 2026 Financial Results and Recent Business Highlights
CABALETTA BIO, INC. (CABA)
Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress
AXSOME THERAPEUTICS, INC. (AXSM)
Axsome Therapeutics Announces Settlement Resolving All SUNOSI® (solriamfetol) Patent Litigation
UPSTREAM BIO, INC. (UPB)
Upstream Bio to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
SCOTTS MIRACLE-GRO CO (SMG)
ScottsMiracle-Gro Reaffirms Fiscal 2026 Guidance, Announces Investor Day Details
GLOBAL PHARMATECH, INC. (OTCM)
OTC Markets Group Welcomes Atomic Eagle Ltd to OTCQX
WESTERN ASSET INTERMEDIATE MUNI FUND INC (EMO)
Emerita Announces Appointments of New Independent Director and Corporate Secretary
FACTSET RESEARCH SYSTEMS INC (FDS)
FactSet Schedules Third Quarter 2026 Earnings Call